Menu
Back to User profile » Mr Bruno Emond
Papers published by Mr Bruno Emond:
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia
Lu X, Emond B, Morrison L, Kinkead F, Lefebvre P, Lafeuille MH, Khan W, Wu LH, Qureshi ZP, Jacobs R
Patient Preference and Adherence 2023, 17:2073-2084
Published Date: 23 August 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1
Donga P, Emond B, Rossi C, Bookhart BK, Lee J, Caron-Lapointe G, Wei F, Lafeuille MH
ClinicoEconomics and Outcomes Research 2023, 15:579-591
Published Date: 24 July 2023
Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B
Biologics: Targets and Therapy 2021, 15:1-15
Published Date: 6 January 2021
Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide
Chow W, Donga P, Côté-Sergent A, Rossi C, Lefebvre P, Lafeuille MH, Hardy H, Emond B
Patient Preference and Adherence 2020, 14:2315-2326
Published Date: 23 November 2020
Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
Pilon D, Joshi K, Tandon N, Lafeuille M, Kamstra RL, Emond B, Lefebvre P
Patient Preference and Adherence 2017, 11:619-629
Published Date: 23 March 2017